Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michelle McBean

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Pathology|September 24, 2022
Clinically relevant variation in FLT3-ITD quantitation as a result of PCR cycle number and ITD insertion sizeIng S Tiong, Nikky Andrieska, Phuong Dang, et al.
Pathology|February 27, 2024
Observations from a national sample exchange program for molecular haematology testingClare Gould, Michelle McBean, Ella Thompson, et al.
Blood|December 13, 2007
Complete molecular response of e6a2 BCR-ABL-positive acute myeloid leukemia to imatinib then dasatinibDavid S Ritchie, Michelle McBean, David A Westerman, et al.
BMC Cancer|April 27, 2013
Quantitative threefold allele-specific PCR (QuanTAS-PCR) for highly sensitive JAK2 V617F mutant allele detectionGiada V Zapparoli, Robert N Jorissen, Chelsee A Hewitt, et al.
Annals of Hematology|February 6, 2017
Clinicopathological differences exist between CALR- and JAK2-mutated myeloproliferative neoplasms despite a similar molecular landscape: data from targeted next-generation sequencing in the diagnostic laboratoryRishu Agarwal, Piers Blombery, Michelle McBean, et al.
Archives of Pathology & Laboratory Medicine|February 10, 2018
Sensitive NPM1 Mutation Quantitation in Acute Myeloid Leukemia Using Ultradeep Next-Generation Sequencing in the Diagnostic LaboratoryPiers Blombery, Kate Jones, Ken Doig, et al.
Cytometry. Part B, Clinical Cytometry|November 22, 2021
Correlation between a 10-color flow cytometric measurable residual disease (MRD) analysis and molecular MRD in adult B-acute lymphoblastic leukemiaJasmine Singh, Malgorzata Gorniak, George Grigoriadis, et al.
Journal of Clinical Pathology|August 13, 2017
Incidental detection of germline variants of potential clinical significance by massively parallel sequencing in haematological malignanciesCostas K Yannakou, Kate Jones, Georgina L Ryland, et al.
International Journal of Molecular Sciences|July 27, 2024
Evaluation of a New Closed-System Automated RT-qPCR Assay for the Rapid Detection and Monitoring of Common Nucleophosmin Mutations in Patients with Acute Myeloid LeukemiaRichard D Press, Dana Dressel, Michelle McBean, et al.
Bone Marrow Transplantation|May 25, 2021
T cell receptor beta locus sequencing early post-allogeneic stem cell transplant identifies patients at risk of initial and recurrent cytomegalovirus infectionJames A Kuzich, Yamuna Kankanige, Jerick Guinto, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Pathology|September 24, 2022
Clinically relevant variation in FLT3-ITD quantitation as a result of PCR cycle number and ITD insertion sizeIng S Tiong, Nikky Andrieska, Phuong Dang, et al.
Pathology|February 27, 2024
Observations from a national sample exchange program for molecular haematology testingClare Gould, Michelle McBean, Ella Thompson, et al.
Blood|December 13, 2007
Complete molecular response of e6a2 BCR-ABL-positive acute myeloid leukemia to imatinib then dasatinibDavid S Ritchie, Michelle McBean, David A Westerman, et al.
BMC Cancer|April 27, 2013
Quantitative threefold allele-specific PCR (QuanTAS-PCR) for highly sensitive JAK2 V617F mutant allele detectionGiada V Zapparoli, Robert N Jorissen, Chelsee A Hewitt, et al.
Annals of Hematology|February 6, 2017
Clinicopathological differences exist between CALR- and JAK2-mutated myeloproliferative neoplasms despite a similar molecular landscape: data from targeted next-generation sequencing in the diagnostic laboratoryRishu Agarwal, Piers Blombery, Michelle McBean, et al.
Archives of Pathology & Laboratory Medicine|February 10, 2018
Sensitive NPM1 Mutation Quantitation in Acute Myeloid Leukemia Using Ultradeep Next-Generation Sequencing in the Diagnostic LaboratoryPiers Blombery, Kate Jones, Ken Doig, et al.
Cytometry. Part B, Clinical Cytometry|November 22, 2021
Correlation between a 10-color flow cytometric measurable residual disease (MRD) analysis and molecular MRD in adult B-acute lymphoblastic leukemiaJasmine Singh, Malgorzata Gorniak, George Grigoriadis, et al.
Journal of Clinical Pathology|August 13, 2017
Incidental detection of germline variants of potential clinical significance by massively parallel sequencing in haematological malignanciesCostas K Yannakou, Kate Jones, Georgina L Ryland, et al.
International Journal of Molecular Sciences|July 27, 2024
Evaluation of a New Closed-System Automated RT-qPCR Assay for the Rapid Detection and Monitoring of Common Nucleophosmin Mutations in Patients with Acute Myeloid LeukemiaRichard D Press, Dana Dressel, Michelle McBean, et al.
Bone Marrow Transplantation|May 25, 2021
T cell receptor beta locus sequencing early post-allogeneic stem cell transplant identifies patients at risk of initial and recurrent cytomegalovirus infectionJames A Kuzich, Yamuna Kankanige, Jerick Guinto, et al.
Pageof 2